A multi-valve centrifugal microfluidic for Mycoplasma pneumoniae detection

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Microfluidics

Background:

• Mycoplasma pneumoniae is a common pathogen requiring rapid detection.
• Microfluidic technology offers advantages in speed and reagent efficiency over traditional methods.
• Balancing detection speed with amplification accuracy is a key challenge in microfluidic diagnostics.

Purpose of the Study:

• To design and validate a centrifugal microfluidic chip for integrated sample lysis, nucleic acid extraction, and amplification of Mycoplasma pneumoniae.
• To optimize the chip design for rapid detection while ensuring amplification efficiency.
• To demonstrate the clinical potential of the developed microfluidic system.

Main Methods:

• Development of a centrifugal microfluidic chip with integrated sample processing steps.
• Utilized Euler force valves, pneumatic centrifugal valves, and siphon valves for sequential reagent release.
• Incorporated a delayed-release structure to enhance nucleic acid concentration.
• Controlled rotational speed for optimized reaction time allocation.

Main Results:

• Qualitative detection of Mycoplasma pneumoniae was achieved in under 10 minutes.
• The chip extracted nucleic acids with a concentration of 74 ng/μl.
• A minimum detection limit of 10^3 copies/ml was established.
• The system demonstrated efficient integration of lysis, extraction, and amplification.

Conclusions:

• The developed centrifugal microfluidic chip enables rapid and accurate detection of Mycoplasma pneumoniae.
• The chip design optimizes nucleic acid concentration and detection time, addressing key challenges in microfluidic diagnostics.
• This technology shows promise for widespread clinical application in infectious disease diagnostics.